Ginkgo bioworks announces presentation at the upcoming american society of gene & cell therapy (asgct) annual meeting

Boston , may 4, 2023 /prnewswire/ -- ginkgo bioworks (nyse: dna), which is building the leading platform for cell programming and biosecurity, today announced its participation in the 26th american society of gene & cell therapy (asgct) annual meeting, may 16-20, in los angeles. ginkgo will present data on its high-throughput screening platform for chimeric antigen receptor (car) libraries, which can enable discovery of car variants with desired characteristics.
DNA Ratings Summary
DNA Quant Ranking